Fundz

Thomas Mitro Named President & Chief Executive Officer of Signal12 Inc.

PRIVATEAug 13, 2024

Position

Chief Executive Officer

Company

Signal12

Thomas Mitro
tmitro@signal12inc.com
GreenwichBiotechnologyHealth CareTherapeutics

Description

Thomas Mitro, the former president and chief operating officer of Aerie Pharmaceuticals, has been recruited to lead Signal12 as president and chief executive officer. The company is readying Pro-ocular™ for Phase 3 trials with a mission to transform the landscape of ocular health.

Quick answer

Thomas Mitro Named President & Chief Executive Officer of Signal12 Inc. (August 13, 2024). Signal12 is based in Greenwich, Connecticut, United States.

Who is the new Chief Executive Officer at Signal12?
Signal12 named Thomas Mitro Chief Executive Officer, announced August 13, 2024.
What did Signal12 announce on August 13, 2024?
Thomas Mitro, the former president and chief operating officer of Aerie Pharmaceuticals, has been recruited to lead Signal12 as president and chief executive officer. The company is readying Pro-ocular™ for Phase 3 trials with a mission to transform the landscape of ocular health.
What does Signal12 do?
Signal12 is a clinical-stage dry eye company that develops novel therapies to address ophthalmic diseases.
Where is Signal12 based?
Signal12 is based in Greenwich, Connecticut, United States.
Which similar companies made leadership changes around the same time?
Pathalys Pharma (August 13, 2024), Pfizer (August 13, 2024), Fore Biotherapeutics (August 12, 2024) and Oculis Holding AG (August 15, 2024) also announced leadership changes within 45 days of Signal12.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Signal12, and when

A new leader at Signal12 brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Signal12 raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Signal12, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Signal12. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Signal12

Location

Greenwich, Connecticut, United States

About

Signal12 is a clinical-stage dry eye company that develops novel therapies to address ophthalmic diseases. Through three Phase 2 clinical studies, the company's proprietary topical drug, Pro-ocular™, has demonstrated efficacy in safely and effectively reducing the signs and symptoms of dry eye disease (DED). Pro-ocular is the first product for DED to utilize transappendageal delivery, and the only product to treat DED by targeting the ophthalmic branch of the trigeminal nerve. The company has offices in Greenwich, CT and Boston, MA.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Signal12 changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Thomas
Likely contact at this company
••••••••@••••••••

See Thomas's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Signal12's next move

Learn about Strategic plan

Signal12 changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.